Call Us Today at 508-231-8842        EMERGENCY

For Immediate Release

Ashland, MA: MEDIcept Inc, an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), and QSIM, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies.

QSIM, under the direction of Brian Markham, President, specialized in providing leadership and resources for organizations undergoing significant quality system change due to remediation, acquisition, or growth.

The merger promotes the shared strategic goal of becoming a leading, international, value-added consulting firm focusing on medical devices and medical technology. This merger offers the opportunity for MEDIcept to more effectively serve their customers, ranging from start-up, virtual medical device manufacturers to Fortune Global 500 firms.

Both MEDIcept and QSIM share a common goal to positively impact medical device compliance and safety. This acquisition provides us with an opportunity to provide medical device manufacturers with value added services as they introduce devices into new markets.

According to F. David Rothkopf, President of MEDIcept, “As part of our strategic plan, MEDIcept is expanding our core competence and expertise in Quality Systems. This merger will provide our clients with greater resource offerings through the QSIM’s deep experience with remediation.”

“This merger will provide QSIM clients with access to a broader group of seasoned industry experts,” said Brian Markham, President of Quality Systems in Motion.  In addition to QSIM’s quality system consulting, MEDIcept will provide our client base with expertise in the areas of clinical studies and regulatory submissions.”


About MEDIcept:

MEDIcept was established in 1996 to offer innovative, trusted, and cost-effective Quality, Regulatory, and Clinical solutions to the medical device and invitro diagnostic industries. With decades of experience, we are uniquely qualified to help clients navigate complex FDA and international regulatory pathways, reduce business risk and time-to-market, while maximizing the potential for success in the market.

About Quality Systems in Motion (QSIM)

QSIM was founded in 2011 to provide expert consultation resources to medical device, biotech, and pharmaceutical organizations facing challenging compliance concerns.

Sign up to receive our Newsletters!

The Latest News

FDA Updates Special 510(k) Guidance

FDA’s Special 510(k) submission process has been around for years as an expedited method to demonstrate that the device to be marketed is at least as safe and effective (i.e., substantially equivalent), to a legally-marketed device not subject to the Premarket Approval (PMA) process. In September 2019, a modified version of this program was published to create a streamlined review of technological changes made to a manufacturer’s own cleared device which leveraged design control requirements....

Metal Implants: FDA’s November, 2019 Immunology Devices Panel Meeting

The Immunology Devices Panel of the FDA’s Medical Device Advisory Committee met in November to discuss the topic of immunological responses to metal-containing products regulated as medical devices. The panel focused on metal-containing implants as well as dental amalgam. Recent post-market issues with some metal-on-metal orthopedic implants and gynecological metal-containing implants have raised questions about the potential for some patients to develop unexpected or heightened biological...

Quality Systems in Motion, Inc. (QSIM) is now part of MEDIcept Inc.

For Immediate Release Ashland, MA: MEDIcept Inc, an international quality, regulatory, and clinical consulting firm focused on medical device and in-vitro diagnostics (IVD), and QSIM, a US-based privately held consulting firm specializing in medical device/biotechnology, announces the merger of the two companies. QSIM, under the direction of Brian Markham, President, specialized in providing leadership and resources for organizations undergoing significant quality system change due to...